Nayak Agencies Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 17-07-2024
- Paid Up Capital ₹ 0.20 M
as on 17-07-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 17-07-2024
- Revenue 14.05%
(FY 2022)
- Profit 262.87%
(FY 2022)
- Ebitda 71.52%
(FY 2022)
- Net Worth 21.92%
(FY 2022)
- Total Assets 17.48%
(FY 2022)
About Nayak Agencies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹1.00 Cr.
Rupa Shah, Jenil Pipalia, Jasmina Pipalia, and Three other members serve as directors at the Company.
- CIN/LLPIN
U51397MH2004PTC145309
- Company No.
145309
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Nayak Agencies Private Limited offer?
Nayak Agencies Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Antipyretic Medication.
Who are the key members and board of directors at Nayak Agencies?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharam Shah  | Director | 05-Mar-2020 | Current |
| Rupa Shah | Director | 01-Apr-2009 | Current |
| Jenil Pipalia | Director | 05-Mar-2020 | Current |
| Jasmina Pipalia | Director | 05-Mar-2020 | Current |
| Sujata Shah | Director | 01-Apr-2009 | Current |
| Nagesh Shah | Director | 01-Apr-2009 | Current |
Financial Performance of Nayak Agencies.
Nayak Agencies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.05% increase. The company also saw a substantial improvement in profitability, with a 262.87% increase in profit. The company's net worth Soared by an impressive increase of 21.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nayak Agencies?
In 2023, Nayak Agencies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Jul 2010 | ₹1.00 Cr | Open |
How Many Employees Work at Nayak Agencies?
Unlock and access historical data on people associated with Nayak Agencies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nayak Agencies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nayak Agencies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
